This is a demo store. No orders will be fulfilled.

Pharmaceuticals and Biotech

  1. 30 Nov 2021  |  Global  |  Technology Research

    Targeted Immunotherapy in Oncology

    Developments in Biotechnology Platforms Leading to Increasing Immuno-oncology Applications

    This research service investigates technologies that propel the development of new targeted immunotherapies, particularly those that deliver therapeutic DNA and proteins. The top 3 growth opportunities focus on enhanced gene delivery systems for greater precision, the support of such systems through novel biotech platforms, and the affordability of...

    $4,950.00
  2. 24 Nov 2021  |  Global  |  Technology Research

    Technology Developments in Viral Vector Manufacturing for Cell and Gene Therapies

    Need for Scalable, Reproducible, and Cost-Effective Manufacturing Processes Driving Growth Opportunities

    The Frost & Sullivan research service discusses the cell and gene therapy (CGT) market and highlights some key roadblocks in viral vector manufacturing. While many CGT candidates exist in the pipeline, there is a huge capacity deficit that the industry is collaboratively trying to address. Scalability, costs, reproducibility, and overall process ef...

    $4,950.00
  3. 22 Nov 2021  |  Global  |  Technology Research

    Technological Advances in RNA Stabilization & Delivery

    LNP- and Bioconjugation-based Nonviral RNA Delivery Technologies to Gain Momentum in the Next 3 Years

    RNA therapeutics is a rapidly expanding field of next-generation medicine. RNA therapy typically comprises 4 different classes of molecules: non-codingRNA (ncRNA), antisense oligonucleotide (ASO), messengerRNA (mRNA), and RNA aptamer. Small ncRNAs are like a double-edged sword; they can either up- or down-regulate specific genes. Contrarily, long...

    $4,950.00
  4. 30 Apr 2021  |  North America  |  Tracker

    US COVID-19 Vaccines and Therapeutics Tracker—Market Insights and Trends, H1 2021

    Agnostic Vaccine Platform Technology Enhancing Future Growth Potential of Participants in the Value Chain

    This study by Frost & Sullivans Healthcare and Life Sciences team provides critical insights into the US COVID-19 vaccines and therapeutics market, including developing vaccines, supply chain considerations, and requirements to manage distribution. The study also identifies actionable and profitable growth opportunities for industry participants. T...

    $2,450.00
  5. 29 Dec 2017  |  Global  |  Technology Research

    Antimicrobial Technologies for Enhanced Consumer Health

    Novel Microbicidal Platforms Likely to Transform the Future of Global Consumer Health

    Healthcare-associated infection (HAI) continues to be a significant global concern, hence there is growing research for developing new antimicrobial platforms that can significantly decrease the risk of microbial infections. While metallic ions continue to be one of the most potent antimicrobial technology platform, several new innovations across a...

    $4,950.00
  6. 29 Dec 2017  |  North America  |  Technology Research

    Innovations in Transdermal Drug Delivery

    Microneedle Technologies Creating Novel Opportunities in Transdermal Drug Delivery Industry

    With the healthcare industry moving toward patient convenience and comfort, pharmaceutical and medical device companies are continuously researching for the most effective, side effect free, convenient route of drug delivery. Transdermal drug delivery is a painless method of delivering drug formulation. Transdermal route of drug administration has ...

    $4,950.00
  7. 29 Dec 2017  |  Global  |  Technology Research

    Emerging Sensor Technologies Transforming Medical Diagnostics

    The Optimal Synergy between Leading-edge Science and Medical Innovation

    TechVisions latest research service profiles innovations in sensing technologies and their impact on clinical diagnosis. The emergence of point of care (PoC) testing has necessitated compact, more portable testing kits, to replace laboratory testing. In the light of global epidemic outbreaks, there is also a greater need for high throughput testing...

    $4,950.00